NASDAQ NMS - GLOBAL MARKET · SGP
-0.85% · -$0.2500 · Vol 608.0K
Market closed · last close 4:00 PM ET · price as of 16:15:00 ET
SpyGlass Pharma Inc

SpyGlass Pharma Inc

Pharmaceuticals
$29.08
Card
Relationship Map

Follow $SGP

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $SGP by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
SGP
SpyGlass Pharma Inc
Sat Sep 19 · market closed · Markets closed · resumes Mon 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

80/ 100
Veridion Score
Upper range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Sat Sep 19 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is SGP moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading SGP catalysts
About SpyGlass Pharma Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2026
Employees
65
Country
US

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$29.25
Day high
$29.47
Day low
$27.33
Previous close
$29.33
52W high
$29.68
-2.02% from high
52W low
$17.56
95% of range
Market cap
$972.7M
P/E
0.84×
EPS
$-0.6100
Beta
1.25
Shares out
33.4M
Volume
608K
5.52× rel vol
Avg volume
110.1K
VWAP
$28.93
Price history computed in-house
1W
+5.67%
1M
+10.87%
3M
+55.51%
SMA 50 $24.84 · above
SMA 200 Not reported · Not reported
52W position 95%

SGP overview

Veridion Score
80
Registered · 2026-09-18
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around SGP.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading SGP Form 4 filings
Public disclosures

Congress activity in SGP

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for SGP in the cached public ledger.

Federal contracts

SGP contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for SGP in this window.
Lobbying spend

SGP lobbying filings, year to date.

Registered lobbying filings matched to SpyGlass Pharma Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for SGP in this window.
Loading news for SGP
Analyst ratings
Sovereign unlock shows live analyst consensus for SGP.
Options
Sovereign unlock shows live options positioning for SGP.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.